ePlus (PLUS) Seeks More Share Flexibility Following Board Proposal As Valuation Debate Builds

ePlus (PLUS) has asked shareholders to approve an increase in authorized common shares from 50,000,000 to 75,000,000 at its September 10, 2026 annual meeting, aiming to provide added flexibility in future financing.

See our latest analysis for ePlus.

The proposed increase in authorized shares comes as ePlus trades at US$89.10, with a 30-day share price return of 11.60% and a 1-year total shareholder return of 33.03%. Short-term momentum has picked up recently, while multi year total shareholder returns remain solid.

If this corporate move has you considering where else growth and capital allocation decisions could matter, it may be worth scanning 18 top founder-led companies

ePlus now trades at US$89.10 while analyst and intrinsic estimates point to very different anchors for fair value. With a fresh authorized share request on the table, how wide is that gap really?

Most Popular Narrative: 19.7% Undervalued

With ePlus at $89.10 against a widely followed fair value line of $111, the narrative sees a substantial gap that hinges on how earnings quality and growth mix evolve from here.

The company's healthy balance sheet, with record cash levels after the financing business sale, enables further investment in organic growth, strategic acquisitions, and expansion into high-growth verticals, all of which can accelerate revenue growth and support long-term EBITDA expansion.

Read the complete narrative.

Want to see what turns that cash pile into a higher fair value for ePlus? The narrative leans on measured revenue growth, steady margins, and a richer future earnings multiple. Curious which detailed forecasts and assumptions have to line up for $111 to make sense?

Result: Fair Value of $111 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the ePlus story also carries some clear pressure points, especially related to margin compression on large enterprise deals and concentrated exposure to a few key customer sectors.

Find out about the key risks to this ePlus narrative.

Another View On ePlus Valuation

While the fair value narrative pegs ePlus at $111, the SWS DCF model points to a future cash flow value of $77.31 with the stock at $89.10. That implies ePlus trades above this cash flow estimate. Which anchor you lean on depends on how much weight you give to modeled cash returns versus earnings-based narratives.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out ePlus for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on ePlus valuation and sentiment, the key question is what matters most to you right now. Act while the information is fresh and review the data directly, then weigh the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond ePlus?

Do not stop with ePlus. Use the Simply Wall Street Screener to spot clear, data backed ideas that could fit your portfolio before others look.

• Target potential mispricing by scanning for companies that appear high quality yet out of favor using the 51 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks that combine higher yields with resilient profiles through the 8 dividend fortresses.
• Prioritise resilience in tougher markets by focusing on companies with healthier finances via the 84 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com